Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Giusy Scandurra"'
Autor:
Giulia Tasca, Clelia Casartelli, Giusy Scandurra, Valentina Guarneri, Claudia Marchetti, Elena Maccaroni, Rocco De Vivo, Claudio Zamagni, Emanuele Baldo Gisone, Emanuele Naglieri, Marilena Di Napoli, Giovanna Scarfone, Vera Loizzi, Ilaria Spagnoletti, Vanda Salutari, Veronica Parolin, Giorgia Mangili, Fabrizio Artioli, G. Ronzino, Germana Tognon, Francesca Martella, Domenica Lorusso, Giusy Ricciardi, Elisabetta De Matteis, Valentina Arcangeli, Rossella Lauria, Cinzia Cardalesi, Sabrina Chiara Cecere, Mariangela Bella, Alberto Andrea Lissoni, Alessandra Bologna, Simona Secondino, Giusi Blanco
Olaparib is the first poly(ADP-ribose) polymerase inhibitor approved as maintenance therapy of recurrent ovarian cancer (OC) patients with a BRCA mutation. To achieve the maximum clinical benefit, adherence to olaparib must be persistent. However, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103efc9b9ffc057b78be4b6f2d67dc1b
http://hdl.handle.net/10281/296019
http://hdl.handle.net/10281/296019
Autor:
Nicla La Verde, A.M. D'Ottavio, Francesco Cognetti, Gianfranco Filippelli, Giusy Scandurra, Cecilia Nisticò, Simonetta Stani, Ida Paris, Daniele Alesini, Grazia Arpino, Marianna Giampaglia, Daniele Santini, Alberto Zambelli, Roberta Caputo, Luca Moscetti, Giovanna Catania, Diana Giannarelli, Michele Caruso, Rosalba Rossello, Paola Malaguti, Katia Cannita, Alessandra Fabi, Vita Leonardi, Filippo Montemurro, Michelangelo Russillo, E. Valle, Mariangela Ciccarese, Gianluigi Ferretti, A. Fabbri, Luisa Carbognin
Publikováno v:
The Breast. 41:137-143
Background We reported the results of an Italian large retrospective analysis that evaluated the effectiveness and safety of T-DM1 in ‘field-practice’ breast cancer patients. We performed a sub-analysis to investigate the clinical activity of T-D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa30bbb305dae5fd40fda85b5132439a
https://doi.org/10.1016/j.breast.2018.07.004
https://doi.org/10.1016/j.breast.2018.07.004
Publikováno v:
Oncologic Breast Surgery ISBN: 9788847054370
Breast cancer during pregnancy is a dramatic event that interrupts one the most joyful aspects of the life of a woman. The diagnostic/therapeutic setting is deeply affected by the presence of a second individual (the fetus) during its intrauterine de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea4be3d1db2f59d24de3e64a2110d6a6
https://doi.org/10.1007/978-88-470-5438-7_10
https://doi.org/10.1007/978-88-470-5438-7_10